Sexuelle Störungen bei Menschen mit einer schizophrenen Erkrankung

Zusammenfassung

Anliegen Überblick über den aktuellen Kenntnisstand zu sexuellen Störungen bei Menschen mit einer schizophrenen Erkrankung. Methode Selektive Literaturübersicht zu Klassifikation, Vorkommen, Auswirkungen und Therapie. Ergebnisse Sexuelle Störungen bei Menschen mit einer schizophrenen Erkrankung werden in ihrer Häufigkeit und subjektiven Bedeutung weitgehend unterschätzt. Schlussfolgerungen Sexualität sollte im Rahmen eines integrativen Behandlungsansatzes stärker berücksichtigt werden. Dies könnte eine umfassendere psychische Stabilisierung der Betroffenen fördern.

Abstract

Objective Overview on the current knowledge concerning sexual dysfunctions in patients with schizophrenia and implications for treatment, compliance, quality of life and partnership. Method Selective literature research on classification, occurrence, effects and therapy. Results Frequency and subjective distress of sexual problems in patients with schizophrenia are widely underestimated. Pharmacogenic and morbogenic causes of the sexual problems are often difficult to differentiate. The low awareness of health care professionals for sexual problems and their persistence have significant negative impact on patients' satisfaction with the treatment, compliance, quality of life and partnership. Conclusions It is important to consider patients' sexuality as an integral part of a treatment approach to achieve compliance and mental stabilization as well as an improvement in quality of life.

Sexualität - sexuelle Nebenwirkungen - Lebensqualität - Partnerschaft - Compliance - psychotische Ersterkrankung

sexuality - sexual side effects - quality of life - partnership - compliance - first-episode psychosis

Literatur

• 1 Kelly D L, Conley R R. Sexuality and schizophrenia: a review.  Schizophr Bull. 2004;  30 767-779
• 2 Grube M, Weigand-Tomiuk H. Sexual dysfunctions in a group of psychiatric in-patients.  Psychiat Prax. 2002;  29 194-200
• 3 Sigusch V. Sexuelle Störungen und ihre Behandlung. Stuttgart, New York; Thieme 2007: 107-141
• 4 Meston C M, Bradford A. Sexual dysfunctions in women.  Annual review of clinical psychology. 2007;  3 233-256
• 5 WHO .ICD-10: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva; World Health Organisation (WHO) 1992
• 6 APA .Diagnostic Criteria from DSM-IV. Washington, DC; American Psychiatric Publishing 1994
• 7 Beutel M E, Stöbel-Richter Y, Daig I. et al . Sexuelles Verlangen und sexuelle Aktivität von Männern und Frauen über die Lebensspanne – Ergebnisse einer repräsentativen deutschen Bevölkerungsumfrage.  J Reproduktionsmed Endokrinol. 2008;  5 203-211
• 8 Dunn K M, Jordan K, Croft P R. et al . Systematic review of sexual problems: epidemiology and methodology.  J Sex Marital Ther. 2002;  28 399-422
• 9 Nazareth I, Boynton P, King M. Problems with sexual function in people attending London general practitioners: cross sectional study.  BMJ. 2003;  327 423
• 10 Laumann E O, Paik A, Rosen R C. Sexual dysfunction in the United States: prevalence and predictors.  JAMA. 1999;  281 537-544
• 11 Fortier P, Mottard J P, Trudel G. et al . Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults.  Schizophr Bull. 2003;  29 559-572
• 12 Hartmann U. Depression and sexual dysfunction: aspects of a multi-faceted relationship.  Psychiat Prax. 2007;  34 (Suppl. 3) S314-317
• 13 Kinzl J F. Sexuality and antipsychotics.  Neuropsychiatr. 2008;  22 49-50
• 14 Bhui K, Puffet A, Herriot P. A survey of sexual problems amongst psychiatric inpatients.  Soc Psychiatry Psychiatr Epidemiol. 1995;  30 73-77
• 15 Smith S M, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication.  Br J Psychiatry. 2002;  181 49-55
• 16 Kammerahl D, Schottle D, Huber C G. Sexualität und Schizophrenie. Eine Übersicht.  Z Sexualforsch. 2008;  21 165-180
• 17 Ferguson J M. The effects of antidepressants on sexual functioning in depressed patients: a review.  J Clin Psychiatry. 2001;  62 (Suppl. 3) 22-34
• 18 Dossenbach M, Hodge A, Anders M. et al . Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation.  Int J Neuropsychopharmacol. 2005;  8 195-201
• 19 Cohen S, Scholz P. Sexualstörungen in der Behandlung depressiver Erkrankungen.  Psychoneuro. 2004;  30 164-168
• 20 Pinderhughes C A, Grace E B, Reyna L J. Psychiatric disorders and sexual functioning.  Am J Psychiatry. 1972;  128 1276-1283
• 21 Akhtar S, Thomson Jr J A. Schizophrenia and sexuality: a review and a report of twelve unusual cases – Part II.  J Clin Psychiatry. 1980;  41 166-174
• 22 Lewis J, Scott E. The sexual education needs of those disabled by mental illness.  Psychiatric Rehabilitation. 1997;  21 164-167
• 23 Miller L J, Finnerty M. Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders.  Psychiatr Serv. 1996;  47 502-506
• 24 McCann E. The expression of sexuality in people with psychosis: breaking the taboos.  J Adv Nurs. 2000;  32 132-138
• 25 Buddeberg C, Furrer H, Limacher B. Sexual problems in schizophrenic patients treated by ambulatory care.  Psychiat Prax. 1988;  15 187-191
• 26 Lukoff D, Gioia-Hasick D, Sullivan G. et al . Sex education and rehabilitation with schizophrenic male outpatients.  Schizophr Bull. 1986;  12 669-677
• 27 Kelly D L, Conley R R. Evaluating sexual function in patients with treatment-resistant schizophrenia.  Schizophr Res. 2003;  63 195-196
• 28 Raja M, Azzoni A. Sexual behavior and sexual problems among patients with severe chronic psychoses.  Eur Psychiatry. 2003;  18 70-76
• 29 Pfeiffer W, Kockott G, Fischl B. et al . Adverse effects of long-term psychopharmacologic therapy on sexual functions.  Psychiat Prax. 1991;  18 92-98
• 30 Aizenberg D, Zemishlany Z, Dorfman-Etrog P. et al . Sexual dysfunction in male schizophrenic patients.  J Clin Psychiatry. 1995;  56 137-141
• 31 Kinzel U, Weig W. Medikamente und ihre Nebenwirkungen auf die Sexualität.  Psychoneuro. 2003;  30 53-56
• 32 Darves-Bornoz J M, Lemperiere T, Degiovanni A. et al . Sexual victimization in women with schizophrenia and bipolar disorder.  Soc Psychiatry Psychiatr Epidemiol. 1995;  30 78-84
• 33 Friedman S, Harrison G. Sexual histories, attitudes, and behavior of schizophrenic and „normal” women.  Arch Sex Behav. 1984;  13 555-567
• 34 Lysaker P H, Meyer P S, Evans J D. et al . Childhood sexual trauma and psychosocial functioning in adults with schizophrenia.  Psychiatr Serv. 2001;  52 1485-1488
• 35 Rosenberg S D, Lu W, Mueser K T. et al . Correlates of adverse childhood events among adults with schizophrenia spectrum disorders.  Psychiatr Serv. 2007;  58 245-253
• 36 Perkins D O. Predictors of noncompliance in patients with schizophrenia.  J Clin Psychiatry. 2002;  63 1121-1128
• 37 Peuskens J, Sienaert P, De Hert M. Sexual dysfunction: the unspoken side effect of antipsychotics.  Eur Psychiatry. 1998;  13 (Suppl. 1) 23s-30s
• 38 Nestoros J N, Lehmann H E, Ban T A. Sexual behavior of the male schizophrenic: the impact of illness and medications.  Arch Sex Behav. 1981;  10 421-442
• 39 Bitter I, Basson B R, Dossenbach M R. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients.  Int Clin Psychopharmacol. 2005;  20 19-21
• 40 Dossenbach M, Dyachkova Y, Pirildar S. et al . Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.  Eur Psychiatry. 2006;  21 251-258
• 41 Kelly D L, Conley R R. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.  Psychoneuroendocrinology. 2006;  31 340-346
• 42 Ghadirian A M, Chouinard G, Annable L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.  J Nerv Ment Dis. 1982;  170 463-467
• 43 Fakhoury W K, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline.  Int Clin Psychopharmacol. 2001;  16 153-162
• 44 Macdonald S, Halliday J, MacEwan T. et al . Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study.  Br J Psychiatry. 2003;  182 50-56
• 45 Demyttenaere K, De Fruyt J, Sienaert P. Psychotropics and sexuality.  Int Clin Psychopharmacol. 1998;  13 (Suppl. 6) S35-S41
• 46 Hartmann U, Ruffer-Hesse C. Sexuality and pharmacotherapy. Medication-induced disorders of sexual response and pharmacotherapeutic options for the treatment of sexual dysfunctions.  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;  50 19-32
• 47 Mancini T, Casanueva F F, Giustina A. Hyperprolactinemia and prolactinomas.  Endocrinol Metab Clin North Am. 2008;  37 67-99, viii
• 48 Mah P M, Webster J. Hyperprolactinemia: etiology, diagnosis, and management.  Semin Reprod Med. 2002;  20 365-374
• 49 Bushe C, Shaw M. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.  J Psychopharmacol. 2007;  21 768-773
• 50 Marken P A, Haykal R F, Fisher J N. Management of psychotropic-induced hyperprolactinemia.  Clin Pharm. 1992;  11 851-856
• 51 Haddad P M, Hellewell J S, Wieck A. Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports.  J Psychopharmacol. 2001;  15 293-295
• 52 Kim K S, Pae C U, Chae J H. et al . Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.  J Clin Psychiatry. 2002;  63 408-413
• 53 Knegtering H, van der Moolen A E, Castelein S. et al . What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?.  Psychoneuroendocrinology. 2003;  28 (Suppl. 2) 109-123
• 54 Weig W, Cohen S, Kuhn K U. et al .Sexualstörungen bei stationär psychiatrisch behandelten Patienten – eine multizentrische Prävalenzstudie. (in Vorbereitung)
• 55 Brunelleschi S, Zeppegno P, Risso F. et al . Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients.  Pharmacol Res. 2003;  48 405-409
• 56 Cutler A J. Sexual dysfunction and antipsychotic treatment.  Psychoneuroendocrinology. 2003;  28 (Suppl. 1) 69-82
• 57 Howes O D, Wheeler M J, Pilowsky L S. et al . Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.  J Clin Psychiatry. 2007;  68 361-367
• 58 Fric M, Laux G. Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine.  Psychiat Prax. 2003;  30 97-101
• 59 Kleinberg D L, Davis J M, de Coster R. et al . Prolactin levels and adverse events in patients treated with risperidone.  J Clin Psychopharmacol. 1999;  19 57-61
• 60 Chue P, Kovacs C S. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.  Bipolar Disord. 2003;  5 (Suppl. 2) 62-79
• 61 Jamerson B, Ashton A K, Houser T. et al .Antidepressant compliance and side effects: Results from a patient survey. New Orleans, LA; Paper presented at the annual meeting of the American Psychiatric Association 2001
• 62 Olfson M, Uttaro T, Carson W H. et al . Male sexual dysfunction and quality of life in schizophrenia.  J Clin Psychiatry. 2005;  66 331-338
• 63 Finn S E, Bailey J M, Schultz R T. et al . Subjective utility ratings of neuroleptics in treating schizophrenia.  Psychol Med. 1990;  20 843-848
• 64 Lambert M, Conus P, Eide P. et al . Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.  Eur Psychiatry. 2004;  19 415-422
• 65 Hellewell J S, Kalali A H, Langham S J. Patient satisfaction and acceptability of long-term treatment wih quetiapine.  Int J Psychiatry Clin Prae. 1999;  3 105-113
• 66 Fleischhacker W W, Meise U, Gunther V. et al . Compliance with antipsychotic drug treatment: influence of side effects.  Acta Psychiatr Scand Suppl. 1994;  382 11-15
• 67 Rosenberg K P, Bleiberg K L, Koscis J. et al . A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance.  J Sex Marital Ther. 2003;  29 289-296
• 68 Strauss B, Gross J. Psychotropic drug-induced changes in sexuality – frequency and relevance in psychiatric practice.  Psychiat Prax. 1984;  11 49-55
• 69 Waldinger M D, Hengeveld M W, Zwinderman A H. et al . Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.  J Clin Psychopharmacol. 1998;  18 274-281
• 70 Gregorian R S, Golden K A, Bahce A. et al . Antidepressant-induced sexual dysfunction.  Ann Pharmacother. 2002;  36 1577-1589
• 71 Mallis D, Moisidis K, Kirana P S. et al . Moderate and severe erectile dysfunction equally affects life satisfaction.  J Sex Med. 2006;  3 442-449
• 72 Laumann E O, Paik A, Rosen R C. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey.  Int J Impot Res. 1999;  11 (Suppl. 1) S60-S64
• 73 Byerly M J, Nakonezny P A, Fisher R. et al . An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.  Schizophr Res. 2006;  81 311-316
• 74 Schimmelmann B G, Paulus S, Schacht M. et al . Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.  J Child Adolesc Psychopharmacol. 2005;  15 249-258
• 75 Fan X, Henderson D C, Chiang E. et al . Sexual functioning, psychopathology and quality of life in patients with schizophrenia.  Schizophr Res. 2007;  94 119-127
• 76 Baldwin D S. Sexual dysfunction associated with antidepressant drugs.  Expert Opin Drug Saf. 2004;  3 457-470
• 77 Targum S D, Dibble E D, Davenport Y B. et al . The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness.  Arch Gen Psychiatry. 1981;  38 562-568
• 78 Ablon S L, Davenport Y B, Gershon E S. et al . The married manic.  Am J Orthopsychiatry. 1975;  45 854-866
• 79 Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: how are they related?.  Br J Psychiatry. 1988;  152 629-631
• 80 Harvey K V, Balon R. Clinical implications of antidepressant drug effects on sexual function.  Ann Clin Psychiatry. 1995;  7 189-201
• 81 Raboch J. Sexual development and life of psychiatric female patients.  Arch Sex Behav. 1986;  15 341-353
• 82 Kockott G, Pfeiffer W. Sexual disorders in nonacute psychiatric outpatients.  Compr Psychiatry. 1996;  37 56-61
• 83 Weisman A G, Nuechterlein K H, Goldstein M J. et al . Controllability perceptions and reactions to symptoms of schizophrenia: a within-family comparison of relatives with high and low expressed emotion.  J Abnorm Psychol. 2000;  109 167-171
• 84 Weig W. Diagnostics and therapy of sexual disorders.  Fortschr Neurol Psychiatr. 2006;  74 665-671; quiz 672–674
• 85 Clayton A H, McGarvey E L, Clavet G J. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.  Psychopharmacol Bull. 1997;  33 731-745
• 86 Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction.  J Clin Psychiatry. 2001;  62 (Suppl. 3) 35-43
• 87 Weig W. Sexual dysfunctions from a neuropsychiatric perspective.  Nervenarzt. 2006;  77 101-108; quiz 109
• 88 Malik P. Sexual dysfunction in schizophrenia.  Curr Opin Psychiatry. 2007;  20 138-142
• 89 Gitlin M. Sexual dysfunction with psychotropic drugs.  Expert Opin Pharmacother. 2003;  4 2259-2269
• 90 Taylor M J, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials.  J Affect Disord. 2005;  88 241-254
• 91 Assem-Hilger E, Kasper S. Psychopharmaka und sexuelle Dysfunktion.  J Neurol Neurochir Psychiatr. 2005;  6 30-36
• 92 Haddad P M, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.  Drugs. 2004;  64 2291-2314
• 93 Kockott G. Psychotherapie sexueller Funktions- und Erlebensstörungen.  Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz. 2007;  50 11-18
• 94 Hauch M. Paartherapie bei sexuellen Störungen. Stuttgart; Thieme 2006